• skype
  • Skype: philippinediver / PH (63) 927-300-6948
  • editormlminsider@yahoo.com
Available Banner

Nature’s Sunshine Reports Second Quarter 2020 Results

PR NEWSWIRE
Nature’s Sunshine Reports Second Quarter 2020 Results

|GlobeNewswire|About: NATR

LEHI, Utah, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Nature’s Sunshine Products, Inc. (Nature’s Sunshine) (NASDAQ: NATR), a leading natural health and wellness company, reported financial results for the second quarter ended June 30, 2020.

Second Quarter 2020 Financial Summary vs. Same Year‐Ago Quarter

  • Net sales were $87.3 million compared to $90.7 million.

  • GAAP net income increased significantly to $6.1 million, or $0.29 per diluted share, compared to $2.6 million, or $0.14 per diluted share. 

  • Adjusted net income per diluted share was $0.28, compared to an adjusted net income per diluted share of $0.15.

  • Adjusted EBITDA increased 21% to $9.7 million compared to $8.0 million.

Management Commentary

“Throughout the second quarter, we continued to navigate the dynamic effects that the COVID-19 pandemic has had on our global markets,” said Terrence Moorehead, CEO of Nature’s Sunshine. “Despite mandated lockdowns across many of our geographies during the quarter, our NSP business returned to revenue growth in two key markets—the U.S. and China. In addition, our commitment to streamlining processes and prudently managing expenses through our ‘Right Stuff’ strategy has helped us deliver significant consolidated net income and adjusted EBITDA growth. I am proud of our global team’s continued hard work and adaptability during this unprecedented time.

“We are continuously adapting to changes in consumer behavior across our business. Demand for our products surged following the onset of the pandemic in mid-March, especially for our immune product line. While the increased demand slowed temporarily in April through mid-May, buying patterns soon stabilized and even accelerated for the remainder of the quarter, potentially signaling a long-term trend towards continued expansion and better engagement with the health-conscious consumer.  

“Looking ahead, we will continue building upon the strong operational foundation we are putting in place with our five global growth strategies, which we call ‘The Fab Five.’ These constitute our key areas of operational focus as we prepare for the launch of our revamped business model in the third quarter. Our revitalized go-to-market plan will enhance our customer and distributor experience by improving our brand presence, including the launch of a revamped consumer-facing e-commerce website, expanding our digital and manufacturing capabilities, and streamlining our organizational structure. There remains much work to be done, but we are pleased with the progress we have made so far and look forward to continuing strong results from our global growth initiatives.”

Second Quarter 2020 Financial Results

 

Net Sales by Operating Segment

 

Three Months
Ended
June 30, 2020

 

Three Months
Ended
June 30, 2019

 

Percent
Change

 

Impact of
Currency
Exchange

 

Percent
Change
Excluding
Impact of
Currency

Asia

$

32,757

 

 

$

35,162

 

 

(6.8

)%

 

$

(872

)

 

 

(4.4

)%

Europe

15,465

 

 

15,075

 

 

2.6

 

 

(232

)

 

 

4.1

 

North America

34,471

 

 

34,620

 

 

(0.4

)

 

(92

)

 

 

(0.2

)

Latin America and Other

4,593

 

 

5,867

 

 

(21.7

)

 

(311

)

 

 

(16.4

)

 

$

87,286

 

 

$

90,724

 

 

(3.8

)%

 

$

(1,507

)

 

 

(2.1

)%

Net sales in the second quarter were $87.3 million compared to $90.7 million in the same year‐ago quarter. The decrease was attributable primarily to the effects of COVID-19-related market closures in South Korea and Latin America. Net sales were also negatively impacted by $1.5 million of unfavorable foreign currency exchange rate fluctuations. This was partially offset by growth in China and Europe.

Gross margin in the second quarter was 73.6% compared to 73.7% the year‐ago quarter.

Volume incentives as a percentage of net sales were 33.4% compared to 34.5% in the year-ago quarter.

Selling, general and administrative expenses in the second quarter decreased 8% to $28.5 million compared to $31.0 million in the year‐ago quarter. The decrease reflects continued savings from restructuring activities in the U.S. and Latin America, decreases in travel and event-related costs as a result of COVID-19, and an unexpected VAT refund in 2020. As a percentage of net sales, SG&A expenses decreased 150 basis points to 32.7% from 34.2% in the second quarter of 2019. Excluding the impact of restructuring and the VAT refund, SG&A expenses as a percentage of net sales were 32.8% in the second quarter of 2020 compared to 33.8% in the year-ago quarter.

Operating income in the second quarter of 2020 increased 45% to $6.6 million, or 7.6% of net sales, compared to $4.5 million, or 5.0% of net sales, in the second quarter of 2019. Excluding the impact of the unusual items noted above, operating income was $6.5 million, or 7.4% of net sales, compared to $4.9 million, or 5.4% of net sales, in the year-ago quarter.

Other income, net, in the second quarter of 2020 was $1.5 million compared to $0.3 million in the second quarter of 2019. Other income, net, primarily consisted of foreign exchange gains as a result of net changes in foreign currencies primarily in Asia, Europe and Latin America. The provision for income taxes was $2.0 million in the second quarter of 2020 compared to $2.2 million for the year-ago quarter.

GAAP net income attributable to common shareholders increased significantly to $5.8 million, or $0.29 per diluted common share, compared to $2.7 million, or $0.14 per diluted common share, in the second quarter of 2019. Net income attributable to NSP China was $1.9 million, or $0.10 per diluted common share, for the second quarter of 2020, compared to a loss of $0.3 million, or $(0.02) per diluted common share, for the second quarter of 2019.

Adjusted net income attributable to common shareholders was $5.6 million, or $0.28 per diluted common share, compared to $2.9 million, or $0.15 per diluted common share, in the prior year period. A reconciliation of adjusted net income to GAAP net income is provided in the attached financial tables.

Adjusted EBITDA increased 21% to $9.7 million in the second quarter compared to $8.0 million in the second quarter of 2019. This increase was driven primarily by the aforementioned net reduction in SG&A. Adjusted EBITDA, which is a non-GAAP financial measure, is defined here as net income from continuing operations before taxes, depreciation, amortization and other income/loss adjusted to exclude share-based compensation expense and certain noted adjustments. A reconciliation of Net Income to Adjusted EBITDA is provided in the financial tables below.

Balance Sheet and Cash Flow

Net cash provided by operating activities was $14.4 million for the six months ended June 30, 2020 compared to $1.1 million used by operating activities in the prior year period. Capital expenditures during the six months ended June 30, 2020 totaled $2.2 million compared to $2.8 million in the comparable period of 2019. As of June 30, 2020, the Company had cash and cash equivalents of $70.3 million and $5.4 million of debt.

Active Distributors and Customers by Segment (1)

 

 

2020

 

2019

 

 

Distributors
& Customers

 

Managers

 

Distributors
& Customers

 

Managers

Asia

 

34,500

 

2,900

 

38,300

 

3,000

Europe

 

88,800

 

4,900

 

85,200

 

4,000

North America

 

76,700

 

4,700

 

78,400

 

4,700

Latin America and Other

 

24,100

 

1,200

 

30,100

 

1,200

 

 

224,100

 

13,700

 

232,000

 

12,900

 

 

 

 

 

 

 

 

 

(1) Active Distributors and Customers include Nature’s Sunshine Products’ independent Distributors and Customers who have purchased our products directly for resale and/or personal consumption during the previous three months ended as of the date indicated. Total Managers, Distributors and Customers, which includes those who have made a purchase in the last twelve months, was 527,900 as of June 30, 2020.

In China, we sell our products through multiple channels, including cross-border e-commerce, wholesale, direct sellers and independent service providers who are compensated for marketing, sales support, and other services.

Conference Call

The Company will hold a conference call today at 5:00 p.m. Eastern time to discuss its second quarter 2020 results.

Date: Thursday, August 6, 2020
Time: 5:00 p.m. Eastern time (3:00 p.m. Mountain time)
Toll-free dial-in number: 1-866-548-4713
International dial-in number: 1-323-794-2093
Conference ID: 7890535

Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Gateway Investor Relations at 1-949-574-3860.

The conference call will be broadcast live and available for replay here and via the Events section of the Nature’s Sunshine website here.  

A replay of the conference call will be available after 8:00 p.m. Eastern time on the same day through August 20, 2020.

Toll-free replay number: 1-844-512-2921
International replay number: 1-412-317-6671
Replay ID: 7890535

About Nature’s Sunshine Products

Nature’s Sunshine Products (NASDAQ: NATR), a leading natural health and wellness company, markets and distributes nutritional and personal care products in more than 40 countries. Nature’s Sunshine manufactures most of its products through its own state-of-the-art facilities to ensure its products continue to set the standard for the highest quality, safety and efficacy on the market today. Additional information about the company can be obtained at its website, www.naturessunshine.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements regarding the Company’s future business expectations, which are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may include, but are not limited to, statements relating to the Company’s objectives, plans, strategies and financial results. All statements (other than statements of historical fact) that address activities, events or developments that the Company intends, expects, projects, believes or anticipates will or may occur in the future are forward-looking statements. These statements are often characterized by terminology such as “believe,” “hope,” “may,” “anticipate,” “should,” “intend,” “plan,” “will,” “expect,” “estimate,” “project,” “positioned,” “strategy” and similar expressions, and are based on assumptions and assessments made by management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties, including the following:

  • adverse impacts of the global COVID-19 pandemic;

  • laws and regulations regarding direct selling may prohibit or restrict our ability to sell our products in some markets or require us to make changes to our business model in some markets;

  • extensive government regulations to which the Company's products, business practices and manufacturing activities are subject;

  • legal challenges to the Company's direct selling program or to the classification of its independent distributors;

  • impact of anti-bribery laws, including the U.S. Foreign Corrupt Practices Act;

  • the Company’s ability to attract and retain independent distributors;

  • the loss of one or more key independent distributors who have a significant sales network;

  • the Company’s joint venture for operations in China with Fosun Industrial Co., Ltd.;

  • registration of products for sale in foreign markets, or difficulty or increased cost of importing products into foreign markets;

  • cybersecurity threats and exposure to data loss;

  • the storage, processing, and use of data, some of which contain personal information, are subject to complex and evolving privacy and data protection laws and regulations;

  • reliance on information technology infrastructure;

  • the effect of fluctuating foreign exchange rates;

  • liabilities and obligations arising from improper activity by the Company’s independent distributors;

  • failure of the Company’s independent distributors to comply with advertising laws;

  • changes to the Company’s independent distributor compensation plans;

  • geopolitical issues and conflicts;

  • negative consequences resulting from difficult economic conditions, including the availability of liquidity or the willingness of the Company’s customers to purchase products;

  • risks associated with the manufacturing of the Company's products;

  • uncertainties relating to the application of transfer pricing, duties, value-added taxes, and other tax regulations, and changes thereto;

  • changes in tax laws, treaties or regulations, or their interpretation;

  • actions on trade relations by the U.S. and foreign governments;

  • product liability claims;

  • the sufficiency of trademarks and other intellectual property rights; and

  • our cannabidiol (CBD) product line is subject to varying, rapidly changing laws, regulations, and rules.

These and other risks and uncertainties that could cause actual results to differ from predicted results are more fully detailed under the caption “Risk Factors” in our reports filed with the Securities and Exchange Commission, including our Annual Report on Form 10-K and Quarterly Reports filed on Form 10-Q.

All forward-looking statements speak only as of the date of this press release and are expressly qualified in their entirety by the cautionary statements included in or incorporated by reference into this press release. Except as is required by law, the Company expressly disclaims any obligation to publicly release any revisions to forward-looking statements to reflect events after the date of this press release.

Non-GAAP Financial Measures

We have included information which has not been prepared in accordance with generally accepted accounting principles (GAAP), such as information concerning non-GAAP net income, Adjusted EBITDA and net sales excluding the impact of foreign currency exchange fluctuations.

We utilize the non-GAAP measures of non-GAAP net income and Adjusted EBITDA in the evaluation of our operations and believe that these measures are useful indicators of our ability to fund our business. These non-GAAP financial measures should not be considered as an alternative to, or more meaningful than, U.S. GAAP net income (loss) as an indicator of our operating performance.

Other companies may use the same or similarly named measures, but exclude different items, which may not provide investors with a comparable view of Nature’s Sunshine Products’ performance in relation to other companies. We have included a reconciliation of Net Income to Adjusted EBITDA, the most comparable GAAP measure. We have also included a reconciliation of GAAP net income to Non-GAAP net income and Non-GAAP Adjusted EPS, in the attached financial tables.

Net sales in local currency removes, from net sales in U.S. dollars, the impact of changes in exchange rates between the U.S. dollar and the functional currencies of our foreign subsidiaries. This is accomplished by translating the current period net sales into U.S. dollars using the same foreign currency exchange rates that were used to translate the net sales for the previous comparable period.

We believe presenting the impact of foreign currency fluctuations is useful to investors because it allows a more meaningful comparison of net sales of our foreign operations from period to period. Net sales excluding the impact of foreign currency fluctuations should not be considered in isolation or as an alternative to net sales in U.S. dollar measures that reflect current period exchange rates, or to other financial measures calculated and presented in accordance with U.S. GAAP.

Investor Relations:

Gateway Investor Relations
Cody Slach
1-949-574-3860

NATR@gatewayir.com  

 

NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Amounts in thousands, except per share information)
(Unaudited)

 

Three Months Ended
June 30,

 

Six Months Ended
June 30,

 

2020

 

2019

 

2020

 

2019

Net sales

$

87,286

 

 

$

90,724

 

 

$

183,212

 

 

$

181,996

 

Cost of sales

23,017

 

 

23,865

 

 

47,698

 

 

47,294

 

Gross profit

64,269

 

 

66,859

 

 

135,514

 

 

134,702

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

Volume incentives

29,165

 

 

31,302

 

 

62,183

 

 

62,315

 

Selling, general and administrative

28,504

 

 

31,019

 

 

59,569

 

 

64,871

 

Operating income

6,600

 

 

4,538

 

 

13,762

 

 

7,516

 

Other income (loss), net

1,509

 

 

306

 

 

(901

)

 

258

 

Income before provision for income taxes

8,109

 

 

4,844

 

 

12,861

 

 

7,774

 

Provision for income taxes

1,976

 

 

2,215

 

 

3,722

 

 

3,416

 

Net income

6,133

 

 

2,629

 

 

9,139

 

 

4,358

 

Net income (loss) attributable to noncontrolling interests

379

 

 

(60

)

 

423

 

 

(88

)

Net income attributable to common shareholders

$

5,754

 

 

$

2,689

 

 

$

8,716

 

 

$

4,446

 

 

 

 

 

 

 

 

 

Basic and diluted net income per common share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic earnings per share attributable to common shareholders

$

0.30

 

 

$

0.14

 

 

$

0.45

 

 

$

0.23

 

 

 

 

 

 

 

 

 

Diluted earnings per share attributable to common shareholders

$

0.29

 

 

$

0.14

 

 

$

0.44

 

 

$

0.23

 

 

 

 

 

 

 

 

 

Weighted average basic common shares outstanding

19,491

 

 

19,291

 

 

19,472

 

 

19,280

 

Weighted average diluted common shares outstanding

19,783

 

 

19,602

 

 

19,725

 

 

19,596

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Amounts in thousands)
(Unaudited)

 

June 30,
2020

 

December 31,
2019

Assets

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

70,255

 

 

$

53,629

 

Accounts receivable, net of allowance for doubtful accounts of $423 and $407, respectively

7,075

 

 

7,319

 

Inventories

50,166

 

 

46,666

 

Prepaid expenses and other

6,577

 

 

5,091

 

Total current assets

134,073

 

 

112,705

 

 

 

 

 

Property, plant and equipment, net

56,687

 

 

59,512

 

Operating lease right-of-use assets

20,572

 

 

23,951

 

Investment securities - trading

1,035

 

 

1,150

 

Intangible assets, net

511

 

 

567

 

Deferred income tax assets

3,977

 

 

4,899

 

Other assets

10,074

 

 

10,284

 

Total assets

$

226,929

 

 

$

213,068

 

 

 

 

 

Liabilities and Shareholders’ Equity

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

4,100 

 

 

$

4,406

 

Accrued volume incentives and service fees

20,172

 

 

18,893

 

Accrued liabilities

25,424

 

 

25,531

 

Deferred revenue

1,845

 

 

1,266

 

Related party notes payable

1,537

 

 

1,518

 

Income taxes payable

2,038

 

 

1,392

 

Current portion of operating lease liabilities

4,416

 

 

4,941

 

Current portion of note payable

2,407

 

 

 

Total current liabilities

61,939

 

 

57,947

 

 

 

 

 

Liability related to unrecognized tax benefits

1,364

 

 

1,499

 

Long-term portion of operating lease liabilities

17,530

 

 

20,213

 

Long-term note payable

2,967

 

 

 

Deferred compensation payable

1,035

 

 

1,150

 

Deferred income tax liabilities

1,645

 

 

1,655

 

Other liabilities

1,214

 

 

1,168

 

Total liabilities

87,694

 

 

83,632

 

 

 

 

 

Shareholders’ equity:

 

 

 

Common stock, no par value, 50,000 shares authorized, 19,510 and 19,410 shares issued and outstanding, respectively

136,661

 

 

135,741

 

Retained earnings

13,409

 

 

4,693

 

Noncontrolling interest

650

 

 

227

 

Accumulated other comprehensive loss

(11,485

)

 

(11,225

)

Total shareholders’ equity

139,235

 

 

129,436 

 

Total liabilities and shareholders’ equity

$

226,929

 

 

$

213,068

 

 

 

 

 

 

 

 

 

 

NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Amounts in thousands)
(Unaudited) 

 

Six Months Ended
June 30,

 

2020

 

2019

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

Net income

$

9,139

 

 

$

4,358

 

Adjustments to reconcile net income to net cash provided by (used in) operating activities:

 

 

 

Provision for doubtful accounts

17

 

 

30

 

Depreciation and amortization

5,070

 

 

4,987

 

Non-cash lease expense

2,257

 

 

2,792

 

Share-based compensation expense

1,130

 

 

851

 

Loss on sale of property, plant and equipment

6

 

 

3

 

Deferred income taxes

912

 

 

365

 

Purchase of trading investment securities

(35

)

 

(57

)

Proceeds from sale of trading investment securities

146

 

 

105 

 

Realized and unrealized losses (gains) on investments

4

 

 

(173

)

Foreign exchange losses (gains)

996

 

 

(205

)

Changes in assets and liabilities:

 

 

 

Accounts receivable

173

 

 

(1,035

)

Inventories

(4,114

)

 

(2,052

)

Prepaid expenses and other current assets

(1,523

)

 

(259

)

Other assets

(69

)

 

(767

)

Accounts payable

(138

)

 

(1,226

)

Accrued volume incentives and service fees

1,523

 

 

(235

)

Accrued liabilities

59

 

 

(6,203

)

Deferred revenue

582

 

 

1,039 

 

Lease liabilities

(2,072

)

 

(2,340

)

Income taxes payable

607

 

 

(1,207

)

Liability related to unrecognized tax benefits

(135

)

 

(40

)

Deferred compensation payable

(115

)

 

125 

 

  Net cash provided by (used in) operating activities

14,420

 

 

(1,144

)

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

Purchases of property, plant and equipment

(2,210

)

 

(2,774

)

  Net cash used in investing activities

(2,210

)

 

(2,774

)

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

Principal payments of revolving credit facility

 

 

(547

)

Proceeds from revolving credit facility

 

 

547

 

Proceeds from note payable

5,374

 

 

— 

 

Tax benefit from stock awards

(210

)

 

(193

)

  Net cash provided by (used in) financing activities

5,164

 

 

(193

)

Effect of exchange rates on cash and cash equivalents

(748

)

 

(186

)

Net increase (decrease) in cash and cash equivalents

16,626

 

 

(4,297

)

Cash and cash equivalents at the beginning of the period

53,629

 

 

50,638

 

Cash and cash equivalents at the end of the period

$

70,255

 

 

$

46,341

 

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:

 

 

 

Cash paid for income taxes, net of refunds

$

2,143

 

 

$

3,895

 

Cash paid for interest

3

 

 

63

 

 

 

 

 

 

 

 

NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES
RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA
 (Amounts in thousands)
(Unaudited)

 

Three Months Ended
June 30,

 

Six Months Ended
June 30,

 

2020

 

2019

 

2020

 

2019

Net income

$

6,133

 

 

$

2,629

 

 

$

9,139

 

 

$

4,358

 

Adjustments:

 

 

 

 

 

 

 

Depreciation and amortization 

2,467

 

 

2,491

 

 

5,070

 

 

4,987

 

Share-based compensation expense 

736

 

 

621

 

 

1,130

 

 

851

 

Other (income) loss, net* 

(1,509

)

 

(306

)

 

901

 

 

(258

)

Provision for income taxes 

1,976

 

 

2,215

 

 

3,722

 

 

3,416

 

Other adjustments (1)

(135

)

 

367

 

 

(635

)

 

1,954

 

Adjusted EBITDA 

$

9,668

 

 

$

8,017

 

 

$

19,327

 

 

$

15,308

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Other adjustments

 

 

 

 

 

 

 

Restructuring related expenses

$

 

 

$

367

 

 

$

 

 

$

1,954

 

VAT refund

(135

)

 

 

 

(635

)

 

 

Total adjustments

$

(135

)

 

$

367

 

 

$

(635

)

 

$

1,954

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

* Other (income) loss, net is primarily comprised of foreign exchange gains (losses), interest income, and interest expense.

 

NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES
RECONCILIATION OF GAAP NET INCOME TO
NON-GAAP NET INCOME and NON-GAAP ADJUSTED EPS
 (Amounts in thousands)
(Unaudited)

 

Three Months Ended
June 30,

 

Six Months Ended
June 30,

 

2020

 

2019

 

2020

 

2019

Net income

$

6,133

 

 

$

2,629

 

 

$

9,139

 

 

$

4,358

 

Adjustments:

 

 

 

 

 

 

 

Restructuring related expenses

 

 

367

 

 

 

 

1,954

 

VAT refund

(135 

)

 

 

 

(635

)

 

 

Tax impact of adjustments

 

 

(140

)

 

 

 

(743

)

Total adjustments

(135 

)

 

227

 

 

(635

)

 

1,211

 

Non-GAAP net income

$

5,998

 

 

$

2,856

 

 

$

8,504

 

 

$

5,569

 

 

 

 

 

 

 

 

 

Reported income attributable to common shareholders

$

5,754

 

 

$

2,689

 

 

$

8,716

 

 

$

4,446

 

Total adjustments

(135

)

 

227

 

 

(635

)

 

1,211

 

Non-GAAP net income attributable to common shareholders

$

5,619

 

 

$

2,916

 

 

$

8,081

 

 

$

5,657

 

 

 

 

 

 

 

 

 

Basic income per share, as reported

$

0.30

 

 

$

0.14

 

 

$

0.45

 

 

$

0.23

 

Total adjustments, net of tax

(0.01

)

 

0.01

 

 

(0.03

)

 

0.06

 

Basic income per share, as adjusted

$

(0.29

)

 

$

0.15

 

 

$

0.42

 

 

$

0.29

 

 

 

 

 

 

 

 

 

Diluted income per share, as reported

$

0.29

 

 

$

0.14

 

 

$

0.44

 

 

$

0.23

 

Total adjustments, net of tax

(0.01

)

 

0.01

 

 

(0.03

)

 

0.06

 

Diluted income per share, as adjusted

$

0.28

 

 

$

0.15

 

 

$

0.41

 

 

$

0.29

 

 

https://ml.globenewswire.com/media/f6dc6d82-1726-4cd1-9542-0db801d859fb/small/nature-s-sunshine-logo-green-jpg.jpg

 

Source: Nature's Sunshine Products, Inc. (NATR) 2020 GlobeNewswire, Inc.

https://seekingalpha.com/pr/17963204-nature-s-sunshine-reports-second-quarter-2020-results

Available Banner

MLM Company
Distributor Contacts

Paul
Paul Taira
ASEA

702-582-5521

tangovision@gmail.com
Distributor Links
Toni
Toni Bishop
PRUVIT

+061 41 60 95313-____

tonibishop_4@hotmail.com
Distributor Links
Kari
Kari Leggett
Rnetwork

509-539-5360

kariaccurate@gmail.com
Distributor Links
Carlos
Carlos de Jesus
inCruises

787-718-3583

procaly@gmail.com
Distributor Links
Sue
Sue Root
It Works Global

315-420-0966

sue@skinnywrapny.com
Distributor Links

SUBSCRIBE TO OUR NEWSLETTER

SUBSCRIBE NOW